Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_assertion type Assertion NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_head.
- NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_assertion description "[14-3-3? attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_provenance.
- NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_assertion evidence source_evidence_literature NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_provenance.
- NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_assertion SIO_000772 24185104 NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_provenance.
- NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_assertion wasDerivedFrom befree-20150227 NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_provenance.
- NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_assertion wasGeneratedBy ECO_0000203 NP786819.RApjkEPVwjbHoUiz6Qoa-_ezbNQLJ83-vr6dMQlzxKxZ0130_provenance.